Prolonged evolution of the human B cell response to SARS-CoV-2 infection
Mrunal Sakharkar(Adimab (United States)), Laura M. Walker(Children's Hospital of Philadelphia), Chengzi I. Kaku(Scripps Institution of Oceanography), Ruth I. Connor(Dartmouth–Hitchcock Medical Center), Wendy Wieland‐Alter(Dartmouth–Hitchcock Medical Center), Anna Z. Wec(Adimab (United States)), Daniel Wrapp(Duke University), C. Garrett Rappazzo(Adimab (United States)), James C. Geoghegan(Adimab (United States)), Emma S. Esterman(Adimab (United States)), Peter F. Wright(Dartmouth College), Ching‐Lin Hsieh(The University of Texas at Austin), Jason S. McLellan(The University of Texas at Austin)
Cited by 201
Related Papers
Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation
|Science|2020|9.8k
Site-specific glycan analysis of the SARS-CoV-2 spike
|Science|2020|1.7k
Structure-based design of prefusion-stabilized SARS-CoV-2 spikes
|Science|2020|1.4k
Immunogenicity and structures of a rationally designed prefusion MERS-CoV spike antigen
|Proceedings of the National Academy of Sciences|2017|1.2k